Stocks
Viatris Inc.VTRS
NASDAQHealthcarePharmaceuticals$13.51-2.10%
A global pharmaceutical manufacturer focused on generic medicines, off‑patent branded drugs, and biosimilars sold across more than 165 countries. Formed from the 2020 combination of Mylan and Pfizer’s Upjohn unit, the company generates significant revenue from legacy brands alongside a broad portfol...
Market Cap: $15.6B52W Range: $6.85 – $16.47
Congressional Interest in Viatris Inc. (VTRS)
17 members of Congress have disclosed 40 trades in Viatris Inc. (VTRS), a Healthcare company. The buy/sell breakdown shows 11 purchases versus 27 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
40
Unique Politicians
17
Buys
11
Sells
27
Who in Congress Is Trading VTRS?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2026-01-29 | Rohit Khanna | sell | $15K – $50K |
| 2025-11-18 | Gilbert Cisneros | buy | $1K – $15K |